Healthcare, Pharma & Life Sciences

CareSource Employees Raise $75,000 for Nevada Children's Cabinet

Image
CareSource Employees Raise $75,000 for Nevada Children's Cabinet

Las Vegas – September 16, 2026 -- Employees of nonprofit managed care organization CareSource raised $75,000 for The Children's Cabinet of Nevada through the company's 2026 Workplace Giving campaign.

CareSource Foundation directs employee-driven giving toward mental health programs

The contribution stems from CareSource's "Together We Give, Together We Impact" campaign, administered by the CareSource Foundation, which this year focuses on addressing the mental health crisis affecting communities nationwide. The Foundation has awarded more than $39 million to nonprofits since 2006, targeting poverty elimination and healthy-community initiatives for low- and moderate-income families.

Seismic Pharma Doses First Patient in Phase 3 Cardiogenic Shock Trial

Durham – September 16, 2026 -- Seismic Pharmaceuticals has enrolled the first patient in RESCUE HF-CS, a global Phase 3 trial testing istaroxime as a potential first-ever approved drug for heart-failure-related cardiogenic shock, a condition with no FDA-approved treatment.

Trial to enroll 600 patients across four continents

The study will recruit approximately 600 patients at clinical sites in the United States, Europe, China and South America. It builds on four completed Phase 2 trials that enrolled more than 350 patients.

Cardiogenic shock carries high mortality despite critical care advances

The condition occurs when the heart cannot pump enough blood to meet the body's needs, cutting oxygen delivery to vital organs. It often complicates acute heart failure or other serious cardiac events, and no pharmacologic therapy has been developed specifically to treat it.

Memorial Healthcare Names Atif Hussein Chief of Cancer Institute

Image
Memorial Healthcare Names Atif Hussein Chief of Cancer Institute

Hollywood, Fla. – September 16, 2026 -- Memorial Healthcare System has appointed Atif M. Hussein, M.D., as chief of Memorial Cancer Institute, capping more than 25 years of physician leadership at the South Florida cancer program.

Hussein built the institute from a handful of oncologists into a comprehensive cancer network

Recruited from Duke University more than two decades ago, Dr. Hussein joined Memorial when its oncology staff was minimal. He since expanded multidisciplinary care, clinical research and graduate medical education, while recruiting nationally recognized physicians to the program.

OnPoint Surgical AR System Hits 1.1mm Spine Screw Accuracy in Peer-Reviewed Study

Concord, Mass. – September 16, 2026 -- OnPoint Surgical's augmented reality navigation system placed pedicle screws with a positional error of 1.1 mm and an angular error of 1.3°, figures 2 to 5 times smaller than those reported for competing navigation and robotic platforms, according to a peer-reviewed study published in the Journal of Spine Surgery.

FARE Launches Anatool, First Point-of-Care Digital Guide for Anaphylaxis

Image
FARE Launches Anatool, First Point-of-Care Digital Guide for Anaphylaxis

Cincinnati – September 16, 2026 -- Food Allergy Research & Education (FARE) has launched Anatool, a digital clinical support tool designed to standardize anaphylaxis recognition and treatment at the point of care for emergency physicians, paramedics, nurses and allergists.

Tool translates international consensus report into bedside guidance

Developed with Tim Dribin, MD, of the Division of Emergency Medicine at Cincinnati Children's, Anatool is built on recommendations from a landmark international consensus report on anaphylaxis published in The Journal of Allergy and Clinical Immunology. Dribin co-chaired that report with Hugh Sampson, MD, of the Icahn School of Medicine at Mount Sinai, and Antonella Muraro, PhD, of the University of Padua.

Prevent Blindness Names National Vision's Fahs 2027 Person of Vision

Chicago – September 16, 2026 -- Prevent Blindness will present its 2027 Person of Vision Award to Reade Fahs, Executive Chairman of National Vision Holdings, Inc., the nation's leading eye-health advocacy organization announced.

Gala set for September 16, 2026, at The Venetian Resort in Las Vegas during Vision Expo

The award ceremony will coincide with Vision Expo, with all proceeds directed toward Prevent Blindness's sight-saving programs.

Fahs led National Vision for 23 years, building one of the largest U.S. optical retail chains

Fahs took the helm of National Vision in 2002 and served as CEO through 2025 before moving into the Executive Chairman role. Under his leadership, the company's portfolio expanded to include America's Best, Eyeglass World, Vista Optical and DiscountContacts.com.

DisposeRx Launches Medication Stewardship Series on Unsafe Drug Disposal

Image
DisposeRx Launches Medication Stewardship Series on Unsafe Drug Disposal

Southern Pines, N.C. – September 16, 2026 -- DisposeRx, Inc. has launched a new monthly editorial series, the DisposeRx Medication Stewardship Center, aimed at reshaping how healthcare providers, pharmacists and caregivers manage the end stage of a prescription's life cycle.

DisposeRx CEO frames disposal as a patient safety issue, not just an environmental one

"This is not simply a conversation about medication disposal. It is a conversation about Medication Safety and completing the prescription journey," said William Simpson, CEO of DisposeRx. He said the starting point for the discussion is the household medicine cabinet, where unused prescriptions commonly accumulate.

Kaiser Permanente Commits $5M to Colorado Schools on Absence Crisis

Image
Kaiser Permanente Commits $5M to Colorado Schools on Absence Crisis

Denver – – September 16, 2026 -- Kaiser Permanente is committing more than $5 million over the next three years to Colorado school districts, targeting rising student chronic absence and staff burnout that have strained education budgets statewide.

Kaiser Permanente Targets Chronic Absence Tied to Health Conditions

The multiyear investment addresses chronic absence rates in Colorado schools that run higher than the national average, a trend the insurer links to underlying health conditions. Districts currently lack granular data to identify why students are missing class, limiting their ability to intervene before absences compound into long-term health and academic setbacks.

Nicklaus Children's Performs Rare Catheter-Based Fontan Procedure on Toddler

Image
Nicklaus Children's Performs Rare Catheter-Based Fontan Procedure on Toddler

Miami – September 16, 2026 -- Nicklaus Children's Hospital Heart Institute has completed one of the first transcatheter-based Fontan procedures performed in the United States, allowing a 2-year-old patient with double-outlet right ventricle to avoid an additional open-heart surgery. The child, born with a complex congenital heart defect, is recovering at home following the procedure.

Catheter-based technique replaces traditional open-heart surgery for Fontan completion

The care team used a catheter-based approach, guiding specialized equipment through a blood vessel to complete the child's Fontan circulation rather than performing conventional open-heart surgery. The Fontan procedure is typically the final stage in a multi-step surgical series for children born with single-ventricle heart defects, rerouting oxygen-poor blood from the body directly to the lungs without passing through a pumping chamber.

Kewaunee Scientific Q1 Sales Fall 6.7% as Backlog Climbs to $169 Million

Image
Kewaunee Scientific Q1 Sales Fall 6.7% as Backlog Climbs to $169 Million

Statesville, N.C. – – September 16, 2026 -- Kewaunee Scientific Corporation (NASDAQ: KEQU) reported first-quarter fiscal 2027 sales of $66.3 million, down 6.7% from $71.1 million a year earlier, even as order backlog rose to $169.0 million from $165.9 million at the end of April.

Net earnings drop to $1.7 million on lower manufacturing volumes

Pre-tax earnings fell 34.7% to $2.56 million from $3.92 million in the prior-year quarter, while net earnings declined to $1.706 million from $3.093 million. Diluted earnings per share came in at $0.58, down from $1.04. EBITDA for the quarter totaled $4.525 million versus $6.32 million a year ago. Backlog, while up sequentially, remains well below the $205.0 million recorded on September 16, 2026.